US EditionPublished • loading... • Updated
Colombia Wins International Process and Will Continue to Produce HIV Medication
Summary by abrilabril.pt
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
In 2023, Colombia declared Dolutegravir (an antiretroviral used to fight HIV) as a public-interest medication. Pharmacists ViiV Healthcare and Shionogi failed to prevent its low-cost production.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
